174 related articles for article (PubMed ID: 24970258)
21. Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
Palmieri G; Satriano SM; Budroni M; Cossu A; Tanda F; Canzanella S; Caracò C; Simeone E; Daponte A; Mozzillo N; Comella G; Castello G; Ascierto PA
BMC Cancer; 2006 Nov; 6():266. PubMed ID: 17107608
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans.
Frenkel S; Zloto O; Pe'er J; Barak V
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):490-3. PubMed ID: 23197685
[TBL] [Abstract][Full Text] [Related]
23. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
24. Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneity.
Fusi A; Berdel R; Havemann S; Nonnenmacher A; Keilholz U
Eur J Cancer; 2011 Sep; 47(13):1971-6. PubMed ID: 21570823
[TBL] [Abstract][Full Text] [Related]
25. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
26. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy.
Eide N; Faye RS; Høifødt HK; Sandvik L; Qvale GA; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
Pathol Oncol Res; 2019 Jan; 25(1):255-262. PubMed ID: 29098521
[TBL] [Abstract][Full Text] [Related]
27. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
28. Screening for uveal melanoma metastasis. Literature review.
Missotten GS; Keunen JE
Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
[TBL] [Abstract][Full Text] [Related]
29. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
[TBL] [Abstract][Full Text] [Related]
30. PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma.
Vaquero-Garcia J; Lalonde E; Ewens KG; Ebrahimzadeh J; Richard-Yutz J; Shields CL; Barrera A; Green CJ; Barash Y; Ganguly A
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4096-4105. PubMed ID: 28828481
[TBL] [Abstract][Full Text] [Related]
31. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
32. Rapid enrichment and detection of melanoma cells from peripheral blood mononuclear cells by a new assay combining immunomagnetic cell sorting and immunocytochemical staining.
Siewert C; Herber M; Hunzelmann N; Fodstad O; Miltenyi S; Assenmacher M; Schmitz J
Recent Results Cancer Res; 2001; 158():51-60. PubMed ID: 11092033
[TBL] [Abstract][Full Text] [Related]
33. Molecular characteristics of liver metastases from uveal melanoma.
Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
[TBL] [Abstract][Full Text] [Related]
34. Morphologically intact melanoma cells may be detected in peripheral blood of melanoma patients.
Benez A; Schiebel U; Fierlbeck G
Recent Results Cancer Res; 2001; 158():113-7. PubMed ID: 11092038
[TBL] [Abstract][Full Text] [Related]
35. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.
Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220
[TBL] [Abstract][Full Text] [Related]
36. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
37. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.
Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189
[TBL] [Abstract][Full Text] [Related]
38. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
[TBL] [Abstract][Full Text] [Related]
39. Mortality after uveal and conjunctival melanoma: which tumour is more deadly?
Kujala E; Tuomaala S; Eskelin S; Kivelä T
Acta Ophthalmol; 2009 Mar; 87(2):149-53. PubMed ID: 18937804
[TBL] [Abstract][Full Text] [Related]
40. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
